Hay fever/Seasonal Allergic Rhinitis and Conjunctivitis (adults) Key Messages Diagnosis and management of seasonal (spring/summer) allergic rhinitis/conjunctivitis. For seasonal allergic rhinitis see separate guidelines. Assessment Bilateral nasal itching, congestion and rhinorrhoea, sneezing, or bilateral conjunctivitis. Differential diagnosis - Perennial rhinoconjunctivitis (non-seasonal) - Infective rhinosinusitis - Non-allergic (eg hormonal, drug-induced, vasomotor) rhinitis For diagnostic algorithm see http://www.bsaci.org/Guidelines/Algorithm-RhinitisPCGL.pdf Red Flags Unilateral symptoms, polyps, persistent blood stained discharge or persistent purulent discharge – consider referral to ENT. Investigations No investigations recommended prior to referral. Management 1. Mild symptoms should be treated with oral non-sedating antihistamines at doses up to twice BNF maximum dosing (cetirizine 10mg, loratadine 10mg, or fexofenadine 180mg up to twice daily). 2. Moderate-severe symptoms should be treated with intranasal corticosteroid (eg Beconase, two sprays into each nostril twice daily; consider trying alternative, eg Nasonex or Avamys) in addition to non-sedating antihistamines. Consistent daily use of intranasal use is vital, given maximal effect may not be apparent for at least two weeks. a. Start antihistamines and intranasal corticosteroids two weeks before usual symptom onset and continue throughout season b. Training in appropriate nasal spray technique essential. Guidance is available at http://www.nationalasthma.org.au/uploads/publication/intranasalcorticosteroid-spray-technique.pdf Version: 3 Date last edited: 10/06/15 Locality: Devon wide Amendments by: Kevin Bishop 3. Systemic corticosteroids (in addition to intranasal corticosteroid) at doses of 15-20mg for a maximum of 5 days as a one-off treatment can be used for severe symptoms uncontrolled on conventional therapy, to control symptoms during important periods (eg exams or other major events). 4. Topical cromoglicate and nedocromil eyedrops are useful to manage allergic conjunctivitis. Consider a concomitant diagnosis of asthma and manage according to guidelines - Montelukast can be added to conventional therapy in patients with seasonal allergic rhinitis and concomitant asthma. Avoid sedating decongestants. antihistamines, depot corticosteroids, and chronic use of Treatment failure should prompt a review of the diagnosis, compliance with therapy (regular therapy is more effective than “as required” treatment), and intranasal corticosteroid technique. Experience from Peninsula Immunology and Allergy Service suggests that 70% of patients referred with severe symptoms achieve satisfactory symptom control using non-sedating antihistamines and regular intranasal corticosteroids alone. For more information see http://www.guidelines.co.uk/eye_ear_nose_throat_bsaci_rhinitis http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2222.2007.02888.x/pdf Referral Referral criteria i) Seasonal symptoms that are severe and resistant to treatment (when combination treatment at maximum doses has been attempted throughout the season). Treatment should be initiated at least 2 weeks before the anticipated start of the pollen season. Referral Instructions Red Flags – refer to ENT Refer via DRSS for NEW Devon CCG patients Choose and Book Selection Specialty: ENT Clinic type: Not otherwise specified Service: DRSS- Western – ENT -NEW Devon CCG - 99p Version: 3 Date last edited: 10/06/15 Locality: Devon wide Amendments by: Kevin Bishop Refer to Peninsula Immunology and Allergy Service Choose and Book Selection Specialty: Allergy Clinic type: Allergy Service: DRSS- Western –Allergy & Immunology - CCG - 99p Referral Forms DRSS Referral form Supporting Information http://www.guidelines.co.uk/eye_ear_nose_throat_bsaci_rhinitis http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2222.2007.02888.x/pdf This guideline has been signed off by the Western Locality on behalf of NEW Devon CCG. Publication date: June 2015 Review date: May 2017 Version: 3 Date last edited: 10/06/15 Locality: Devon wide Amendments by: Kevin Bishop